Biliary Imaging Flashcards

1
Q

MRCP imaging techniques

A

MRCP = T2 weighted sequences to view fluid in biliary tract/surrounding structures

fast spin echo sequences

intremediate T2 (TE 80-100ms) best suited for biliary ductal syste

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

advantages/disadvantages of MRCP over ERCP

A

Advantages

  • MRCP has the ability to see extra-luminal findings.
  • MRCP can visualize excluded (obstructed) ducts.
  • MRCP is non-invasive.

Disadvantages

  • MRCP does not allow for concurrent therapeutic intervention.
  • MRCP does not actively distend the biliary ductal system with contrast. -MRCP has worse spatial resolution compared to ERCP.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

gadoxetic acid disodium

A

Eovist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

gadobenate dimeglumine

A

Multihance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

contrast enhanced MRCP

A

FS T1 weighted with gadolinium contrast agents with biliary excretion

short T1 relaxation resulting in T1 hyperintense biliary fluid (20-45 min delay to allow for biliary excretion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Todani system

A

divides choledochal cysts based on number, distribution, morphology

type I: fusiform dilation
type II: extrahepatic saccular dilation
type III: intraduodenal bile duct dilation
type IV: multiple segments dilated
type V: intrahepatic dilation/caroli disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

choledochal cysts vs hamartomas

A

choledochal cysts communicate with biliary tree

hamartomas do not communicate with biliary tree

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

biliary anatomic variants

A

low insertion of cystic duct

aberrant right posterior duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

aberrant right posterior duct clinical significance

A

right hepatic liver donor; 2 right hepatc ducts must be anastomosed separately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

when are choledochal cysts diagnosed? increased risk?

A

childhood; increased risk for cholangiocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

most common type of extrahepatic cyst

A

type 1 choledochal cyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

caroli disease association

A

polycystic kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

caroli syndrome

A

caroli disease + hepatic fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

central dot sign

A

CECT: small branch of portal vein and hepatic artery dilated bile ducts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

type of cholcystitis seen in ICU pts

A

acalculus colecystitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CT diagnosis of acute cholecystitis

A

gallbladder wall thickening >3mm
pericholecystic fluid
gallbladder hyperemia
galbladder calculi

17
Q

complications of acute cholecystitis

A

gangrenous cholecystitis, gallbladder perforation, emphysematous cholecystitis

18
Q

gangrenous cholecystitis cause? treatment?

A

increased intraluminal pressure&raquo_space; wall ischemia

wall thickening asymmetric/intraluminal membranes present

treat: emergent cholecystectomy/cholecystostomy

19
Q

acute gallbladder perforation complications

A

subacute peroration&raquo_space; pericholecystic abscess

bile peritonitis

cholecystoenteric fistula

20
Q

emphysematous cholecystitis

A

gas forming bacteria in the lumen/wall of gallbladder

typical patient: elderly diabetic

treatment: emergent cholecystectomy/cholcystostomy; conservative in high risk patients

21
Q

porcelain gallbaldder

A

peripherally calcified gallbladder wall, thought to be sequelae of chronic cholecystitis

controversial increased risk of gallbladder carcinoma; treatment with non-emergent cholecystectomy

22
Q

Charcot’s triad

A

fever, abdominal pain, jaundice

23
Q

most common cause of ascending cholangitis

A

choledocholithiasis

24
Q

imaging findings of ascending cholangitis

A

hyperenhancement/thickening of walls of bile ducts; often with CBD stone

25
PSC, associations, complications
idiopathic inflammator destruction of bile ducts associated with UC, more common in males cirrhosis, cholangiocarcinoma, recurrent biliary imagings
26
PSC imaging characteristics
beaded, irregular appearance of CBD and intrahepatic bile ducts
27
PSC mimic
HIV cholangiopathy; although HIV cholangitis is more associated iwth papillary stenosis
28
PBC
inflammation/destruction of smaller bile ducts than PSC middle aged women --> pruritis --> hepatic cirrhosis
29
AIDS cholangitis
biliary infection with ryptosporidium and CMV; present with RUQ pain, fever, elevated LFTs papillary stenosis (different than PSC)
30
recurrent pyogenic cholangitis/oriental cholangiohepatitis
parasie: clonorchis sinesis pigment stone formation, biliary stasis, cholangitis indigenous to SE asia recurrent jaundice/fevers increased risk of cholangiocarcinoma
31
triad of recurrent pyogenic cholangitis
pneumobilia, lamellated bile duct filling defects, intrahepatic/extrahepatic bile duct dilation/strictures
32
biliary cystadenoma
benign cystic neoplasm in middle aged women; does not communicate with biliary system abdominal pain, n/v, obstructive jaundice; may be large may recur after resection
33
biliary cystadenoma imaging
large multiloculated cystic mass; septations distinguish from simple cyst no thick enhancing wall large solid component/thick calcificationshould raise concern for cystadenocarcinoma
34
cholangiocarcinoma
malignant tumor of biliary ductal epithelium --> duct obstruction and intrahepatic ductal dilation, capsular retraction >> lobar atrophy hilar tumor at intrahepatic ducts is known as Klatskin tumor
35
risk factors for cholangiocarcinoma
Choledochal cyst(s). Primary sclerosing cholangitis. Familial adenomatous polyposis syndrome. Clonorchis sinensis infection. Thorium dioxide (alpha-emitter contrast agent), not used since the 1950s. Thorium dioxide is also associated with angiosarcoma and HCC.
36
gallbladder carcinoma
chronic gallblader inflammation >> carcinoma scirrhous infiltrating mass that invades through wall into liver; sometimes polypoid mass, rarelymural thickening
37
gallbladder metastasis
melanoma